Why the study?
Is higher mean platelet volume associated with myocardial perfusion defects in patients with type 2 diabetes?
Is higher mean platelet volume associated with myocardial perfusion defects in patients with type 2 diabetes?
Answers are grounded in this paper and cite their sources.
Higher mean platelet volume is independently associated with myocardial perfusion defects in patients with type 2 diabetes, suggesting it may serve as a non-invasive indicator of myocardial ischemia.
AIM: Our aim was to evaluate whether there was a relationship between mean platelet volume and myocardial perfusion defect in diabetic patients using myocardial perfusion imaging. METHODS: Forty-four diabetic patients with myocardial perfusion defect (group 1) and 44 diabetic patients without myocardial perfusion defect (group 2), matched for age and gender, were retrospectively examined. Levels of mean platelet volume (MPV) in the two groups were assessed. RESULTS: MPV was higher in group 1 than group 2 patients (8.76 ± 0.76 and 8.25 ± 0.78 fl), respectively, p = 0.003). Levels of glucose, triglycerides (TG), total cholesterol (TC), low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, haemoglobin (Hb) and glycosylated haemoglobin (HbA1c), and body mass index (BMI) in the two groups were not statistically significantly different. Multivariate logistic regression analyses showed that MPV was the only variable independently associated with myocardial perfusion defects (OR: 2.401, 95% CI: 1.298-4.440, p = 0.013). CONCLUSION: This study showed that higher MPV was associated with myocardial perfusion defects. Higher MPV in diabetic patients was independently related to myocardial perfusion defects and may be an indicator of myocardial ischaemia.
No takes yet. Share an insight, caveat, or question.
Sarıkaya et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: